4//SEC Filing
DECICCO CARL 4
Accession 0001562180-21-007666
CIK 0001822462other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 8:37 PM ET
Size
9.6 KB
Accession
0001562180-21-007666
Insider Transaction Report
Form 4
DECICCO CARL
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-09$3.72/sh+104,310$388,033→ 362,707 total - Exercise/Conversion
Stock Options (Right to buy)
2021-12-09−27,418→ 34,273 totalExercise: $3.72Exp: 2029-02-20→ Common Stock (27,418 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2021-12-09−76,892→ 186,571 totalExercise: $3.72Exp: 2029-02-20→ Common Stock (76,892 underlying)
Footnotes (2)
- [F1]The option vested as to 25% of the underlying shares of common stock on December 10, 2019, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
- [F2]The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001828727
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 8:37 PM ET
- Size
- 9.6 KB